Abstract
Purpose: Treatment of hormone receptor-positive early breast cancer (HR+EBC) in patients who are unfit for or decline radical treatment requires careful consideration of tumour parameters against functional status, co-morbidities and quality of life. In this retrospective study we reviewed the outcomes of patients treated with primary endocrine therapy (PET) in a single UK centre.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
